Session 7: RWE, Data Sharing and Data Transparency
René Allard, PhD
The future of clinical evidence will be determined by the willingness to share data. There are numerous important components in striving for the maximum clinical utility that was identified by the Institute of Medicine in 2015. A culture of sharing with effective incentives is essential, including that stakeholders can identify the platform that is most appropriate for their needs. The panellists will share insights into different initiatives for data sharing and give insights on evolving voluntary data sharing models. Presentation and Q&A session.
Insights on How to Prepare and Plan Data Collection: Nikolai Constantin Brun, MD
Co-Chair, EMA-MHA Big Data Task Force; Dir, Div for Medical Eval & Biostatistics
Danish Medicines Agency, Denmark
Federated Networks to Improve Trust: Nigel Hughes, MSc
Scientific Director, Observational Health Data Analytics/Epidemiology
Janssen Research and Development, Belgium
Finding New Solutions to Problems and Concerns in Clinical Data Sharing – Outcomes from Datathon (REMOTE via Zoom): Rebecca Li, PhD
Executive Director, Center for Global Clinical Research Data
Vivli , United States
Have an account?